The NHS in England is launching a world-first trial of a “gamechanging” artificial intelligence tool that can identify patients at risk of type 2 diabetes more than a decade before they develop the condition.
More than 500 million people worldwide have type 2 diabetes, and finding new ways to spot people at risk before they develop the condition is a major global health priority. Estimates suggest 1 billion people will have type 2 diabetes by 2050.
The condition is a leading cause of blindness, kidney failure, heart attacks, strokes and lower limb amputation. It is often linked to being overweight or inactive, or having a family history of type 2 diabetes, although not all those diagnosed are in those categories.
